Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of Indias only vertically integrated, purpose-designed Cell and Gene Therapy (CGT) Infrastructure and Viral Vector Production Facility at Genome Valley in Telanganas Hyderabad expanding its expertise from vaccine innovation to leading-edge regenerative and personalised therapies that promise hope for millions, said a release.